Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Madame Bioscience PCLBKK:MADAME -3.13%21 Days Payable is 44.08 as of Mar. 2026, which is 11% above its 10-year median of 39.73. GuruFocus rates BKK:MADAME with a GF Score™ of 21/100 and a GF Value™ of ฿0.64 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,891 Consumer Packaged Goods companies, Madame Bioscience PCL ranks better than 57.48% on this metric.
The historical rank and industry rank for Madame Bioscience PCL's Days Payable or its related term are showing as below:
BKK:MADAME'
s Days Payable Range Over the Past 10 Years
Min: 33.53 Med: 39.73 Max: 65.82
Current: 51.13
During the past 13 years, Madame Bioscience PCL's highest Days Payable was 65.82. The lowest was 33.53. And the median was 39.73.
BKK:MADAME's Days Payable is ranked better than 57.48% of 1891
companies
in the Consumer Packaged Goods industry
Industry Median: 44.15
vs BKK:MADAME: 51.13
Madame Bioscience PCL Days Payable Historical Data
* Premium members only.
The historical data trend for Madame Bioscience PCL's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Madame Bioscience PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Madame Bioscience PCL Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Madame Bioscience PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Madame Bioscience PCL's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Madame Bioscience PCL's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Madame Bioscience PCL (BKK:MADAME) has a Days Payable of 44.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Madame Bioscience PCL and its competitors. This is 11% above median its historical median of 39.73. Over the past decade, Madame Bioscience PCL's Days Payable has ranged from 33.53 to 65.82. According to the industry distribution chart, Madame Bioscience PCL ranks #804 out of 1891 companies in the Consumer Packaged Goods industry, placing it in the top 42.5%.
Is Madame Bioscience PCL's Days Payable too high?
Madame Bioscience PCL's current Days Payable of 44.08 is 11% above median its 10-year median of 39.73. Over the past 10 years, this metric has ranged from a low of 33.53 to a high of 65.82. The Consumer Packaged Goods industry median Days Payable is 44.15. Madame Bioscience PCL's value of 44.08 is 0.2% below this industry median. Based on the distribution chart, Madame Bioscience PCL ranks #804 out of 1891 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Madame Bioscience PCL has a GF Score™ of 21/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Madame Bioscience PCL's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Madame Bioscience PCL ranks #804 out of 1891 companies for Days Payable. This puts Madame Bioscience PCL in the upper half of its industry. The industry median Days Payable is 44.15. Madame Bioscience PCL's value of 44.08 is 0.2% below this benchmark. Historically, Madame Bioscience PCL's own Days Payable has ranged from 33.53 to 65.82 over the past decade. While the company's 10-year median is 39.73 vs. the industry median of 44.15, Madame Bioscience PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,891 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Madame Bioscience PCL's current Days Payable of 44.08 is 0.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Madame Bioscience PCL and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Madame Bioscience PCL's current Days Payable is 44.08, which is 11% above median its own 10-year median of 39.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madame Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, Madame Bioscience PCL (BKK:MADAME) is currently considered Fairly Valued. The stock's GF Value™ is ฿0.64, compared to a current price of ฿0.62 — trading 3.1% below its estimated fair value. The current Days Payable is 44.08, which is 11% above median its 10-year median of 39.73 and 0.2% below the Consumer Packaged Goods industry median of 44.15. Madame Bioscience PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Madame Bioscience PCL (BKK:MADAME), the current Days Payable is 44.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Madame Bioscience PCL (BKK:MADAME) Overvalued in 2026?
Based on GuruFocus' analysis, Madame Bioscience PCL stock appears to be undervalued.
The current stock price of ฿0.62 is trading 3.1% below its estimated GF Value™ of ฿0.64.
GuruFocus considers Madame Bioscience PCL to be Fairly Valued.
Key valuation signals for BKK:MADAME:
Days Payable: 44.08 (11% above median its 10-year median of 39.73)
GF Value™: ฿0.64 vs. price of ฿0.62 (3.1% below fair value)
Industry Position: 0.2% below the Consumer Packaged Goods median (#804 of 1891)
No single metric tells the full story. See the BKK:MADAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Madame Bioscience PCL is engaged in the segments of the Packaging business, Food business, Retail sales of cosmetics, and Other businesses. Its activities include the manufacturing and selling of plastic packaging, restaurant business, advertising rental service in the gas station and manufacturing and selling of dried fruits, among others. The group derives a majority of its revenue from the Food business. The firm's product portfolio includes Ready meals, Frozen food, value-added seafood and vegetables, Flexible packaging, and PET Bottles.
21GF Score
Get the complete analysis for BKK:MADAME
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MADAME has been successfully added to your 
